Tonix Pharmaceuticals HoldinTNXP

13F holders, Q4 2024 (December 31)
2holders
$0.33avg. 13F price*

At the end of Q4 2024, 2 institutions reported holding Tonix Pharmaceuticals Holdin (TNXP) in their 13F filings. The largest holders were North Star Investment Management Corp. ($2K) and Anchor Investment Management, LLC ($38).

Company
Tonix Pharmaceuticals Holdin
CUSIP
890260839
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q4 2024: 2Q4 2024Q1 2025: 25Q1 2025Q2 2025: 47Q2 2025Q3 2025: 60Q3 2025Q4 2025: 70Q4 2025Q1 2026: 81Q1 2026Q2 2026: 101Q2 2026

Total Exit/New Position Q4 2024

InstitutionsTotal Value
New Positions2$2K
Exits0$0

Ownership 2 holders

North Star Investment Management Corp. 0.00% New 5,262 $2K
Anchor Investment Management, LLC 0.00% New 115 $38

"% of holder's portfolio" is TNXP's weight in each manager's 13F, not the share of Tonix Pharmaceuticals Holdin the manager owns.